海南海药(000566) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥189,408,874.14, a decrease of 10.36% compared to the same period last year[5] - The net profit attributable to shareholders was -¥84,000,150.87, with a year-to-date loss of -¥242,307,257.15[5] - The basic and diluted earnings per share were both -¥0.0647 for the current period[5] - Total operating revenue for the current period is CNY 639,683,832.92, a decrease of 20.5% compared to CNY 804,727,228.88 in the previous period[21] - The company reported a net loss of ¥262,645,523.82 for the current period, compared to a net loss of ¥313,678,925.17 in the previous period, representing an improvement of approximately 16.3%[22] - Operating profit (loss) for the current period was ¥-258,156,904.69, compared to ¥-305,059,177.96 in the previous period, indicating a reduction in losses by about 15.3%[22] - The company’s total comprehensive loss for the current period was ¥263,166,228.46, compared to a loss of ¥314,027,001.89 in the previous period, showing an improvement of about 16.3%[22] - Basic and diluted earnings per share were both reported at ¥-0.1868, an improvement from ¥-0.2275 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,790,095,764.09, down 5.29% from the end of the previous year[5] - The equity attributable to shareholders decreased by 47.01% to ¥278,371,317.30 compared to the previous year-end[5] - Current liabilities increased to CNY 4,359,829,200.30 from CNY 4,299,131,641.34, indicating a rise of 1.4%[19] - The company's total liabilities decreased to CNY 5,467,732,524.80 from CNY 5,523,151,531.94, a decrease of 1.0%[19] - The company's cash and cash equivalents decreased to CNY 259,728,662.81 from CNY 329,624,399.72, a decline of 21.1%[18] - Long-term equity investments slightly decreased to CNY 422,800,067.93 from CNY 429,519,914.71, a reduction of 1.6%[18] Cash Flow - Cash flow from operating activities for the year-to-date was ¥25,873,667.52, showing a significant improvement from -¥67,262,673.90 in the same period last year[9] - Cash flow from operating activities generated a net inflow of ¥25,873,667.52, a significant recovery from a net outflow of ¥67,262,673.90 in the previous period[23] - The company received cash from financing activities amounting to ¥2,303,823,616.13, compared to ¥3,048,072,741.84 in the previous period, reflecting a decrease of approximately 24.4%[24] - The company’s cash outflow from investing activities was ¥117,272,070.86, slightly down from ¥129,324,421.62 in the previous period[23] Expenses - Research and development expenses decreased by 52.86% to ¥27,335,705.41 compared to the previous year[9] - Sales expenses were reduced by 44.45% to ¥113,371,830.98, indicating effective control over market development costs[9] - The company's research and development expenses decreased to CNY 27,335,705.41 from CNY 57,982,852.49, a reduction of 52.9%[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 74,037[11] - The largest shareholder, Hainan Huadong Industrial Co., Ltd., holds 22.89% of shares, totaling 296,989,889 shares, with 148,494,944 shares pledged[11] - Shenzhen Nanfang Tongzheng Investment Co., Ltd. holds 10.28% of shares, totaling 133,346,318 shares, with 130,825,900 shares frozen[11] - Yunnan International Trust Co., Ltd. holds 5.26% of shares, totaling 68,295,512 shares[11] Legal and Financial Obligations - The company is pursuing legal action against Southern Tongzheng and others for a total debt of 311,169,942.04 RMB plus interest[15] - The company has a total of 101 properties mortgaged as collateral, with priority after certain banks[14] - The company has signed multiple agreements regarding debt transfer and compensation since December 2020[16] Other Financial Metrics - The company reported a significant increase in other payables by 75.84% to ¥1,898,667,712.80, primarily due to financial support from the controlling shareholder[9] - The company recorded a net investment income of ¥6,038,962.20, a recovery from a loss of -¥50,014,917.00 in the previous year[9] - The company's net investment income is CNY 6,038,962.20, a significant recovery from a loss of CNY 50,014,917.00 in the previous period[21] - The total assets decreased to CNY 5,790,095,764.09 from CNY 6,113,528,499.69, representing a decline of 5.3%[20] - The company's other comprehensive income after tax attributable to the parent company was ¥-520,704.64, compared to ¥-348,076.72 in the previous period, indicating a decline in comprehensive income[22]